POPULARITY
2 episodes with cdc advisory committee
2 episodes with cdc advisory committee
CDC Advisory Committee issue vaccine guidelines for flu season; Smallpox vaccine gains expanded indication; Updated Novavax COVID-19 vaccine; Over-the-counter gel for erectile dysfunction; New inserter system for placement of contraceptive intrauterine system.
Thank you for joining us for another episode of OccPod. In this episode, Erin and Dr. Nabeel are joined by Dr. Amy Behrman for a conversation about COVID-19 and outbreaks of Measles, and how workers can protect themselves. Dr. Behrman is the Medical Director of Occupational Medicine Services and Professor of Emergency Medicine at the Hospital of the University of Pennsylvania. Dr. Behrman serves on the National Adult and Influenza Immunization Summit which is dedicated to improving vaccine use as recommended by the CDC Advisory Committee on Immunization Practices.
Our hosts cover the latest news on Medicare price negotiations, new CDC data on asthma related emergency visits, and the RSV vaccine. For the main topic, The Health Advocates take a look at yet another COVID variant and its potentially worrisome mutations, the rise in COVID related ER visits, masking practices, and what this means for the fall booster shot. “And you know, despite the increase, just going back to the point, I just made it still far below what we've seen in the U.S. in the past, the current level of COVID hospitalizations is a third of it was a year ago at this time,” says Zoe Rothblatt, Associate Director of Community Outreach at GHLF. Among the highlights in this episode: 00:52: Zoe explains that the Biden administration is set to announce a list of the first 10 drugs up for negotiation by Medicare in an effort to lower prescription drug prices, as a result of the recently passed Inflation Reduction Act 01:43: Steven Newmark, Director of Policy at GHLF, shares new CDC data that found asthma related emergency department visits were 17 percent higher than expected in the U.S. on days when the wildfires in Canada carried heavy smoke into part of the U.S. 02:41: Steven and Zoe discuss the recent FDA approval of a vaccine for RSV (Respiratory Syncytial Virus) aimed at protecting infants through vaccinating pregnant people in the latter part of pregnancy 03:22: Steven and Zoe talk about a new COVID variant, Pirola, which has been seen in multiple countries and has 36 mutations that is worrying experts 06:23: Steven and Zoe discuss the increase in emergency department visits and COVID hospitalizations in the southeastern states of the U.S., but note that it is still far below the levels seen in the past 08:26: Steven and Zoe discuss the upcoming CDC Advisory Committee meeting on September 12 to discuss recommendations for the next COVID vaccine 09:46: What our hosts learned from this episode Contact Our Hosts Steven Newmark, Director of Policy at GHLF: snewmark@ghlf.org Zoe Rothblatt, Associate Director, Community Outreach at GHLF: zrothblatt@ghlf.org We want to hear what you think. Send your comments in the form of an email, video, or audio clip of yourself to thehealthadvocates@ghlf.org Catch up on all our episodes on our website or on your favorite podcast channel.See omnystudio.com/listener for privacy information.
In this week's podcast, NACCHO Government Affairs team members Adriane Casalotti and Kerry Allen provide an update on the status of federal funding and discuss NACCHO's priorities for a possible Fiscal Year 2023 omnibus appropriations bill. They also review the progress made on legislation to establish a public health loan repayment program, and ongoing NACCHO efforts to get that across the finish line before the 117th Congress ends, including an upcoming opportunity for NACCHO members to engage with their federal lawmakers in support of the program. Adriane describes the implications of and discussion around the recent CDC Advisory Committee on Immunization Practices recommendations on the COVID-19 vaccine. Finally, the team reminds listeners that many public health policy decisions will hinge on the outcome of the upcoming midterm elections and urges everyone to vote. Later in the program, we talk about one of the latest outbreaks – monkeypox (MPX) – with Dr. Philip Huang, Director of the Dallas County Health and Human Services, Andy Meléndez Salgado, MPH, Manager of the Public Health Emergencies and Environmental Health Unit of the New Orleans Health Department, and Dr. Judith Shlay, Associate Director of the Public Health Institute at Denver Health. We discuss how local health departments are working to reach populations at risk for MPX and how lessons learned from COVID-19 response are helping local jurisdictions to address MPX.
Thank you for joining us for another episode of OccPod, the official podcast of the American College of Occupational and Environmental Medicine. This episode serves as a continuation of a special series investigating vaccinations. Funding for this series was made possible (in part) by the Centers for Disease Control and Prevention. In this episode, Erin and Dr. Nabeel are joined by guest Dr. Amy Behrman to discuss updates to COVID-19 vaccinations, including the latest bivalent boosters. Dr. Behrman is the Medical Director of Occupational Medicine Services and Professor of Emergency Medicine at the Hospital of the University of Pennsylvania. She serves on the National Adult and Influenza Immunization Summit which is dedicated to improving vaccine use as recommended by the CDC Advisory Committee on Immunization Practices. As always, thank you for joining us for OccPod. Don't forget to subscribe so you can hear the latest information related to occupational and environmental medicine, vaccinations, and a host of other topics!
The CDC Advisory Committee is meeting this week to discuss adding COVID vaccines to the CDC Childhood Immunization Schedule. Protect your child. Let your voice be heard.
In a season that's usually dominated by the Flu, this year we find ourselves looking at a full menu of vaccine options. There's the Flu shot. COVID boosters. Vaccines for Monkeypox, Shingles, and Polio .. and who knows what's next. Dr. Ruth Karron knows. Fair Media Council CEO and Executive Director Jaci Clement chats with this global health expert and Director of the Johns Hopkins Vaccine Initiative about the safety of all of these vaccines for adults — and children, too! — and explores common misconceptions and misinformation dispensed through mainstream media. ABOUT RUTH KARRON, M.D. Ruth Karron, M.D., is a Professor of International Health in the Bloomberg School of Public Health with a joint appointment in the Department of Pediatrics in the School of Medicine, Johns Hopkins University. Dr. Karron is a pediatric infectious diseases physician, virologist, and vaccinologist, and is Director of the Johns Hopkins Vaccine Initiative. Dr. Karron has substantial experience in the evaluation of respiratory virus vaccines in adult and pediatric populations. Dr. Karron's research interests also include the development of immune responses to respiratory viral infections in early life, the epidemiology of RSV and other respiratory viral diseases in low resource settings, and public policy and ethical issues related to vaccine development and distribution. She co-led the Pregnancy Research Ethics for Vaccines, Epidemics, and New Technologies (PREVENT) Working Group, which released “Pregnant Woman & Vaccines Against Emerging Epidemic Threats: Ethics Guidance for Preparedness, Research and Response”, a guidance document with specific actionable recommendations to ensure that pregnant women are no longer excluded from receiving vaccines against emerging infectious diseases, and was co-developer of the COVID-19 Maternal Immunization Tracker (www.comitglobal.org ). Dr. Karron has been a member of a number of national and international vaccine advisory committees and panels, including the CDC Advisory Committee on Immunization Practices (ACIP), the Gavi Vaccine Innovation Prioritisation Steering Committee (VIPS), and the COVAX ACT-accelerator COVID vaccine Maternal Immunization Working Group, and has chaired the FDA Vaccine and Related Biological Products Advisory Committee (VRBPAC) and the Vaccines Advisory Panel for the Wellcome Trust. She is currently deputy chair of the WHO Product Development for Vaccines Advisory Committee (PDVAC). In 2016, Dr. Karron received the Robert M. Chanock award for outstanding contributions to RSV research. ABOUT FMC FAST CHAT FMC Fast Chat is the podcast of the Fair Media Council, a 501c3 nonprofit organization advocating for quality news and working to create a media-savvy society. Notables in media, news and business are regularly interviewed on the FMC Fast Chat podcast. Please subscribe wherever you listen to podcasts. Guest inquiries: bookings@fairmediacouncil.org Learn more about your ad choices. Visit megaphone.fm/adchoices
In a season that's usually dominated by the Flu, this year we find ourselves looking at a full menu of vaccine options. There's the Flu shot. COVID boosters. Vaccines for Monkeypox, Shingles, and Polio .. and who knows what's next. Dr. Ruth Karron knows. Fair Media Council CEO and Executive Director Jaci Clement chats with this global health expert and Director of the Johns Hopkins Vaccine Initiative about the safety of all of these vaccines for adults — and children, too! — and explores common misconceptions and misinformation dispensed through mainstream media. ABOUT RUTH KARRON, M.D. Ruth Karron, M.D., is a Professor of International Health in the Bloomberg School of Public Health with a joint appointment in the Department of Pediatrics in the School of Medicine, Johns Hopkins University. Dr. Karron is a pediatric infectious diseases physician, virologist, and vaccinologist, and is Director of the Johns Hopkins Vaccine Initiative. Dr. Karron has substantial experience in the evaluation of respiratory virus vaccines in adult and pediatric populations. Dr. Karron's research interests also include the development of immune responses to respiratory viral infections in early life, the epidemiology of RSV and other respiratory viral diseases in low resource settings, and public policy and ethical issues related to vaccine development and distribution. She co-led the Pregnancy Research Ethics for Vaccines, Epidemics, and New Technologies (PREVENT) Working Group, which released “Pregnant Woman & Vaccines Against Emerging Epidemic Threats: Ethics Guidance for Preparedness, Research and Response”, a guidance document with specific actionable recommendations to ensure that pregnant women are no longer excluded from receiving vaccines against emerging infectious diseases, and was co-developer of the COVID-19 Maternal Immunization Tracker (www.comitglobal.org ). Dr. Karron has been a member of a number of national and international vaccine advisory committees and panels, including the CDC Advisory Committee on Immunization Practices (ACIP), the Gavi Vaccine Innovation Prioritisation Steering Committee (VIPS), and the COVAX ACT-accelerator COVID vaccine Maternal Immunization Working Group, and has chaired the FDA Vaccine and Related Biological Products Advisory Committee (VRBPAC) and the Vaccines Advisory Panel for the Wellcome Trust. She is currently deputy chair of the WHO Product Development for Vaccines Advisory Committee (PDVAC). In 2016, Dr. Karron received the Robert M. Chanock award for outstanding contributions to RSV research. ABOUT FMC FAST CHAT FMC Fast Chat is the podcast of the Fair Media Council, a 501c3 nonprofit organization advocating for quality news and working to create a media-savvy society. Notables in media, news and business are regularly interviewed on the FMC Fast Chat podcast. Please subscribe wherever you listen to podcasts. Guest inquiries: bookings@fairmediacouncil.org Learn more about your ad choices. Visit megaphone.fm/adchoices
Dom welcomes back Dr. Marty Makary, author of The Price We Pay: What Broke American Healthcare…and How To Fix It, to discuss a report that the CDC Advisory Committee on Immunization Practices would be voting on whether to add the COVID-19 to the childhood immunization schedule, with Dr. Makary expressing why he's not there yet to require something like this. Then, Giordano asks Makary about a report out of Boston University about a new strain of COVID developed in a lab that has a 80% kill rate, which kicks off a conversation about gain-of-function research and whether this is at all beneficial to the health of Americans. (Photo by Getty Images)
Full Hour | In today's third hour, Dom welcomes back Megan Brock, a mom from out in Bucks County, who along with other parents continues their crusade to understand what's being done inside schools, particularly centered on Coronavirus lockdowns. Today, Brock presented in Harrisburg to State Senate a new bill for parental rights along with State Senator and Gubernatorial Candidate Doug Mastriano. Brock tells about the new bill presented by the State Senator, stressing the necessity for transparency from both the State government and local school boards when determining decisions on curriculum and lockdowns. Then, Dom welcomes back Dr. Marty Makary, author of The Price We Pay: What Broke American Healthcare…and How To Fix It, to discuss a report that the CDC Advisory Committee on Immunization Practices would be voting on whether to add the COVID-19 to the childhood immunization schedule, with Dr. Makary expressing why he's not there yet to require something like this. Then, Giordano asks Makary about a report out of Boston University about a new strain of COVID developed in a lab that has a 80% kill rate, which kicks off a conversation about gain-of-function research and whether this is at all beneficial to the health of Americans. (Photo by Getty Images)
Dr. Paul Offit is a pediatrician specializing in infectious diseases and an expert on vaccines, immunology, and virology. He is the co-inventor of a rotavirus vaccine that has been credited with saving hundreds of lives every day. Dr. Offit is the Maurice R. Hilleman professor of vaccinology, professor of pediatrics at the Perelman School of Medicine at the University of Pennsylvania and director of The Vaccine Education Center at Children's Hospital of Philadelphia (CHOP). Offit is currently a member of National Institutes of Health (NIH) working group on vaccines, a subgroup of the "Accelerating COVID-19 Therapeutic Interventions and Vaccines" (ACTIV) comprised of experts to combat COVID-19. He is also a member of the FDA's Vaccines and Related Biological Products Advisory Committee (VRBPAC). Previously, he was a member of the Centers for Disease Control and Prevention's (CDC) Advisory Committee on Immunization Practices. Offit is a board member of Vaccinate Your Family, The Franklin Institute, and Autism Science Foundation. "You Bet Your Life" is his 12th book.Find out more about Dr. Offit and this episode at: https://www.nicupodcast.com________________________________________________________________________________________As always, feel free to send us questions, comments or suggestions to our email: nicupodcast@gmail.com. You can also contact the show through instagram or twitter, @nicupodcast. Or contact Ben and Daphna directly via their twitter profiles: @drnicu and @doctordaphnamd. enjoy!This podcast is proudly sponsored by Chiesi.
This week on Pharm5: Stem cell transplant led to HIV remission Pyrukynd approved for PK-deficient hemolytic anemia TicoVac recommended for tick-borne encephalitis New PBM regulation passed in Michigan FTC fails to pass PBM investigation proposal Connect with us! Listen to our podcast: Pharm5 Watch us on TikTok: @LizHearnPharmD Follow us on Twitter: @LizHearnPharmD References: HIV: Stem cell transplant may have cured woman. Medical News Today. https://www.medicalnewstoday.com/articles/stem-cell-treatment-may-have-cured-woman-of-hiv#Not-a-universal-cure. Accessed February 24, 2022. FDA approvals roundup: Pyrukynd and Solosec. Regulatory Affairs Professionals Society (RAPS). https://www.raps.org/news-and-articles/news-articles/2022/2/fda-approvals-roundup-pyrukynd-nalmefene-hcl-solos. Accessed February 24, 2022. Pyrukynd [package insert]. U.S. Food and Drug Administration Website. https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/216196s000lbl.pdf. Revised February 2022. CDC Advisory Committee on Immunization Practices Votes to recommend ticovac™, Pfizer's tick-borne encephalitis (TBE) vaccine, for those at risk of virus exposure. Pfizer. https://www.pfizer.com/news/press-release/press-release-detail/cdc-advisory-committee-immunization-practices-votes. Accessed February 24, 2022. Morgan LW, Knowles EP, 17 F. Michigan Pharmacy Benefit Manager (PBM) Bill Passes the Senate. Frier Levitt - Attorneys at Law. https://www.frierlevitt.com/articles/michigan-pharmacy-benefit-manager-pbm-bill-passes-the-senate/. Published February 17, 2022. Accessed February 24, 2022. Barrett J. PBM reform legislation progresses in Michigan. Drug Topics. https://www.drugtopics.com/view/pbm-reform-legislation-progresses-in-michigan. Published March 26, 2021. Accessed February 24, 2022. Pharmacypracticenews.com. https://www.pharmacypracticenews.com/Online-First/Article/02-22/FTC-Votes-Against-Investigating-PBMs-Effects-on-Specialty-Pharmacies/66213. Accessed February 24, 2022. Rowland D. Federal Trade Commission rejects Pharmacy Benefit Managers Probe pushed by Biden appointee. The Columbus Dispatch. https://www.dispatch.com/story/news/2022/02/17/prescription-drug-costs-ftc-declines-go-after-pbms-despite-pharmacists-testimony/6787109001/. Published February 18, 2022. Accessed February 24, 2022.
Pregnant and recently pregnant individuals who become infected with the COVID-19 virus are at high risk of requiring extra medical care. JAMA Associate Editor Linda Brubaker, MD, MS, from University of California San Diego discusses the rapidly evolving data around COVID-19 and vaccine effectiveness and safety as it relates to pregnancy, breastfeeding, and fertility with 3 experts in the field: Laura E. Riley, MD, from Weill Cornell Medicine, Christina Chambers, PhD, MPH, from University of California San Diego School of Medicine-Pediatrics, and Denise Jamieson, MD, MPH, from Emory University. Related Content: COVID-19 and Pregnancy COVID-19 Vaccination During Pregnancy: Maternal Protection and Neonatal Immunity Widespread Misinformation About Infertility Continues to Create COVID-19 Vaccine Hesitancy Conflict of Interest Disclosures: Dr Chambers reported receiving research funding from Pfizer-BioNTech to study the safety of its COVID-19 vaccine in pregnancy. Dr Jamieson reported no disclosures. Dr Riley reported receiving compensation from UpToDate for work on several infections disease cards, receiving royalties from Turner Publishing, and serving on an advisory board for Maven. Dr Riley also reported serving on a CDC Advisory Committee on Immunization Practices workgroup on COVID-19 vaccines and vaccine safety and workgroups for the American College of Obstetricians and Gynecologists and Society for Maternal-Fetal Medicine of COVID-19 vaccination, without compensation.
Pregnant and recently pregnant individuals who become infected with the COVID-19 virus are at high risk of requiring extra medical care. JAMA Associate Editor Linda Brubaker, MD, MS, from University of California San Diego discusses the rapidly evolving data around COVID-19 and vaccine effectiveness and safety as it relates to pregnancy, breastfeeding, and fertility with 3 experts in the field: Laura E. Riley, MD, from Weill Cornell Medicine, Christina Chambers, PhD, MPH, from University of California San Diego School of Medicine-Pediatrics, and Denise Jamieson, MD, MPH, from Emory University. Related Content: COVID-19 and Pregnancy COVID-19 Vaccination During Pregnancy: Maternal Protection and Neonatal Immunity Widespread Misinformation About Infertility Continues to Create COVID-19 Vaccine Hesitancy Conflict of Interest Disclosures: Dr Chambers reported receiving research funding from Pfizer-BioNTech to study the safety of its COVID-19 vaccine in pregnancy. Dr Jamieson reported no disclosures. Dr Riley reported receiving compensation from UpToDate for work on several infections disease cards, receiving royalties from Turner Publishing, and serving on an advisory board for Maven. Dr Riley also reported serving on a CDC Advisory Committee on Immunization Practices workgroup on COVID-19 vaccines and vaccine safety and workgroups for the American College of Obstetricians and Gynecologists and Society for Maternal-Fetal Medicine of COVID-19 vaccination, without compensation.
Dr. Jennie and Dr. Sawyer cover the following topics in episode 3 of season 2 KidzDocTalk:-Percentage of eligible children vaccinated-Purpose and goal for Covid vaccines-Each family's risk/benefit analysis-Family interactions when a member is infected-Avoiding exposure, transmission, infection and reinfection-What underlying conditions are being seen in hospitalized children-Current trends, peaks and surges-Children not eligible for the Covid vaccine yet-Overloaded hospitals-Outdoor gatherings/activities without masking but still distanced-Importance of ventilation-The efficiency of social distancing and masks two years into the pandemic-Living with Covid in the future About Dr. Mark Sawyer:Dr. Sawyer is a Professor of Clinical Pediatrics and a Pediatric Infectious Disease specialist at the UCSD School of Medicine and Rady Children's Hospital San Diego. He is the medical director of the UCSD San Diego Immunization Partnership, a contract with the San Diego County Agency for Health and Human Services to improve immunization delivery in San Diego. He is a past member of the American Academy of Pediatrics Committee on Infectious Diseases, the FDA Vaccines and Related Biological Products Advisory Committee (VRBPAC) and the CDC Advisory Committee on Immunization Practices (ACIP) and is an Associate Editor of the AAP Red Book. Recently he was recalled to VRBPAC to work on the FDA approval of COVID vaccines
Pfizer recipients 65 and older and those living in long-term care facilities would be eligible for a booster. People ages 18 to 64 with an underlying health condition would be eligible too. Learn more about your ad choices. Visit megaphone.fm/adchoices
The medical safety net ensuring vaccine safety is historic, says Henry Bernstein, DO, MHCM, FAAP, a voting member of the Advisory Committee on Immunization Practices (ACIP) of the Centers for Disease Control and Prevention (CDC), and a professor of pediatrics at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. 00:55 - Dr. Bernstein explains his role on the ACIP 03:02 - He explains the four reporting programs they use to monitor and learn from data on possible reactions to vaccines. Three of those have been around for many years, with the CDC's V-safe after vaccination health checker a new addition during COVID-19. V-safe: a text messaging-based system that enables people who received the COVID-19 vaccine to report any post-vaccine side effects via a free app. Users receive weekly messages for up to six weeks; then three-, six-, and 12-month check ins after the final dose of vaccine. Users are also reminded to get the second vaccine dose and a check-in afterward about their experience. VAERS (Vaccine Adverse Event Reporting System): a national database to which providers, vaccine manufacturers and the public can report side effects. The "early warning system" provides the CDC and FDA with information that helps identify health concerns and ensure vaccine safety. Clinical Immunization Safety Assessment Project (CISA): a national network of vaccine safety experts from the CDC's Immunization Safety Office (ISO) and medical research centers. There are seven centers around the county that serve as consultants around these less common events and also do research relating to vaccine safety, as well as work with health care providers when vaccine safety questions arise, or adverse events following immunization occur domestically. Vaccine Safety Datalink (VSD): yet another monitoring system created by the CDC that gathers electronic health record data from nine participating integrated health care organizations on more than 12 million people each year. 07:34 - Dr. Bernstein shares insights from recent ACIP meetings reviewing reports of myocarditis and pericarditis following vaccination with either the Pfizer or Moderna mRNA vaccines. 10:57 - ACIP's latest meeting in July focused on reports of Guillain-barre syndrome (GBS) after inoculation using the J&J vaccine. Of the roughly 100 reported cases of GBS in the US among recently vaccinated individuals (with the J&J vaccine), not all cases have been confirmed as GBS. 13:41 - In both cases - myocarditis, pericarditis and GBS, patients recover well. Emergency use authorization fact sheets, available to the public, now contain information about these findings to help inform individuals getting the vaccines. 16:33 - The 3 guiding principles of the CDC Advisory Committee on Immunization Practices (ACIP). ------------------------ Watch episodes of 20-Minute Health Talk on YouTube. In addition to a professor of pediatrics, Dr. Bernstein is an Ex-Officio member of the American Academy of Pediatrics' (AAP) Committee on Infectious Disease (COID Red Book Committee) and Associate Editor of Red Book Online. He is board certified by the American Board of Pediatrics.
Please share this interview with people not yet vaccinated and people questioning being vaccinated. It's so important people realise the real irreversible danger posed by the Covid vaccine. Thankyou.For more expert opinion on various subjects, visit paperview.uk!!Paper View: In Print covers a wide range of subjects encompassing the entire spectrum of society, explaining clearly and simply the connections, placing current events in their true context, including an exposure of the Covid-19 pandemic hoax, examining every element of the story and its impact on human society, and is now available at:https://paperview.uk/store/paper-view-in-print-physical-bookDr. Janci Chunn Lindsay is the Director of Toxicology and Molecular Biology for Toxicology Support Services, LLC. She holds a doctorate (PhD) in Bochemistry and Molecular Biology from the University of Texas Graduate School of Biomedical Sciences, M.D. Anderson Cancer Center-Houston. Dr. Lindsay has extensive experience in analyzing the molecular profile of pharmacologic responses as they pertain to the dose/response relationship. Her expertise centers on evaluating the complex dynamics of toxicity, such as toxicant pharmacology, exposure route, host metabolism, and subsequent cellular effects as they relate to the contribution of specific substances to impairment, health risk, or human disease. Dr. Lindsay has over 30 years of scientific experience with an emphasis on the study of inhalation toxicology involving pulmonary pathologies such as asthma, reactive airway disease, chronic obstructive pulmonary disease (COPD), asbestosis, mesothelioma and pulmonary fibrosis—that may be claimed following chemical, drug, or particulate exposure. Dr. Lindsay also has experience in performing health risk assessments and evaluating the toxicological profile of a variety of consumer and industrial products, chemicals and pollutants. Dr. Lindsay also has experience in analyzing and evaluating molecular markers of disease in the modern field of “Toxicogenomics”, particularly with respect to benzene and asbestos. Additonally, Dr. Lindsay performs forensic toxicology investigations with respect to cases involving drugs their effects and alcohol cases involving issues of impairment of pyschomotor functions.Dr. Lindsay recently spoke at a meeting of the CDC Advisory Committee on Immunisation Practices outlining her views on the Covid-19 vaccine and its potential for impacting fertility and sterility, as well as causing blood clots and blood disorders. I will be talking with Dr. Lindsay about these issues and more. Dr Lindsay had a short time limit for her speech at the ACIP but was given ample time with no censorship in this interview.I look forward to clearing up some of the confusion currently circulating about the Covid vaccine.
Louisville Lectures Internal Medicine Lecture Series Podcast
Dr. Forest Arnold returns to present "COVID-19 Vaccines: Wows and Woes" today on Louisville Lectures. In this presentation, Dr. Arnold gives an overview of COVID-19 and vaccines. He then discusses a case of potential thrombosis due to the Johnson & Johnson vaccine as well as the pathophysiology of vaccine-induced immune thrombotic thrombocytopenia (VITT). After, he presents the CDC Advisory Committee on Immunization Practices and the efficacy of vaccines in light of variants. And finally, Dr. Arnold discusses post acute COVID-19 Syndrome (PACS). Some items in this lecture may have come from the lecturer’s personal academic files or have been cited in-line or at the end of the lecture. For more information, see our citation page. Disclaimers ©2016 LouisvilleLectures.org
President Joe Biden has a big and consequential week ahead as he prepares to mark his first 100 days in office and deliver his first address to a joint session of Congress. But the Biden to-do list is as big as the Biden already done list. Plus, new signs that the U.S. vaccine supply could soon outpace demand. And concern from the White House as 8% of Americans are missing their second shot. But first, the family of Andrew Brown Jr. is calling for the release of the full, unredacted police body camera footage to be released in the wake of his death in a police-related incident in North Carolina last week. On today's program: CNN's Elie Honig, Phil Mattingly, Lauren Fox, Kaitlan Collins, and Joan Biskupic. Also on the show: Retired LAPD Sergeant Cheryl Dorsey; Astead Herndon and Maggie Haberman with the New York Times; and Dr. Kevin Ault with the CDC Advisory Committee on Immunization Practices. To learn more about how CNN protects listener privacy, visit cnn.com/privacy
An influential Covid-19 model from the University of Washington predicts there will be 562,000 deaths by April 1st. If 95% of people wore masks, 55,000 lives could be saved. Dr. Chris Murray is the director of the group at the University of Washington that’s been working on these models throughout the pandemic. He joins AC360 to discuss when he thinks the vaccines will make a major dent on the daily death rate. Plus, the FDA has issued emergency use authorization for Moderna’s Covid-19 vaccine. Dr. William Schaffner is a professor at the Division of Infectious Diseases at Vanderbilt University Medical Center and is also a member of the CDC Advisory Committee on Immunization Practices. He tells AC360 that getting the Moderna vaccine to rural hospitals and health departments will be much easier because it doesn’t have the intense, cold storage requirements that the Pfizer vaccine has. Airdate: December 18, 2020 Guests: Dr. Chris Murray Dr. William SchaffnerTo learn more about how CNN protects listener privacy, visit cnn.com/privacy
Where Medicine Meets Ministry: Dr. Sheri Talks Faith & Facts
In this episode we cover:Why should African-American women know specifically about TNBC?What can AA women do and where can they go to arm themselves with knowledge regarding TNBC?What is the Black Breast Cancer Alliance?The importance of choosing life in every thing that you do!Know your HER story—what's your health issue?Changing your life will require you to let go of your dependencies.What is SMAD?---Sisters Making A Difference. Create your own group of supporters who can share valuable resources with each other.Don't wait till you are told you are going to die to find your purpose. Your peace is non-negotiable. Finding your filter for dealing with stress to get to peace.Ricki Fairley is an 8-year Stage 3A survivor/thriver of TNBC. She is spearheading a movement to address #BlackBreastCancer as a disease that warrants special attention and focus by Pharma. Ricki's personal purpose, passion, mission, ministry and blessing is to raise awareness, fundraise for a cure for breast cancer and support and coach what she calls her “Breastie” sisters through their breast cancer experience. Ricki is building a movement and the Black Breast Cancer Alliance to address Black Breast Cancer as a unique and special disease state, with the overall goal of reducing the mortality rate for Black women. Ricki founded and serves as co-host for “The Doctor Is In,” a weekly live web series on the BlackDoctor.org Facebook page. She serves on the Board of Trustees for the Triple Negative Breast Cancer Foundation where she spearheads the Marketing Committee and directs multicultural outreach. She established a presence for the Foundation in African American targeted media/social media vehicles. She is a board member for the Center for Healthcare Innovation, a non-profit research and educational institute making healthcare more equitable. She also serves as an Ambassador and Advisor for the Live Humanly Campaign and works with companies to provide the patient advocate voice for breast cancer drug development. She serves on the National Accreditation Program for Breast Centers (NAPBC) Advocacy and Outreach Committee, and the CDC Advisory Committee on Breast Cancer in Young Women. She writes regularly for BlackDoctor.org, Black Health Matters, the Cincinnati Herald and the Black Press.Email: rickifairley@gmail.comBrand/Organization Name: DOVE MarketingWebsite: dove.marketingTOUCH, The Black Breast Cancer AllianceFacebook, Twitter, Instagram: @TouchBBCAFacebook: Ricki FairleyTwitter: @rickidove Instagram: @rickidove
Listen Now The Emergency Medical Treatment and Labor Act (EMTALA) was passed in 1986 under the Reagan administration to help prevent patient dumping. The law requires hospitals to provide emergency medical treatment to anyone regardless of citizenship, legal status or ability to pay. In recent years however hospitals have begun to impose upfront emergency room fees. Today approximately half of all hospitals do so. Hospital executives claim these fees reduce ER overcrowding by diverting patients with non-emergency needs. Patient advocates claim the fees undermine EMTALA's intent and causes patients' health conditions to worsen. For example, in 2011 one large national hospital chain saw 80,000 patients leave their emergency rooms untreated when faced with a $150 use fee. During this 17 minute podcast Professor Rosenbaum explains what generally EMTALA requires, when ER fees can be legally solicted or collected, the negative effects of fee collection, she questions the legitimacy of the industry's argument that fees help to encourage more appropriate site of care use and what can be done to provide better oversight and enforcement of EMTALA. Professor Sara Rosenbaum is the Harold and Jane Hirsh Professor of Health Law and Policy and Founding Chair of the Department of Health Policy at The George Washington University School of Public Health and Health Services. Professor Rosenbaum is best known for her work on the expansion of Medicaid and community health centers, patients' rights in managed care, civil rights and health care, and national health reform. She is the lead author of Law and the American Health Care System, a landmark textbook that provides an in-depth exploration of the interaction of American law and the U.S. health care system. She has received numerous national awards for her work, serves on governmental advisory committees, private organizational and foundation boards, and is a past Chair of AcademyHealth. She is a member of the CDC Director's Advisory Committee, the CDC Advisory Committee on Immunization Practice and a Commissioner on the Medicaid and CHIP Payment and Access Commission (MACPAC). She received her BA from Wesleyan and her JD from Boston University. This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit www.thehealthcarepolicypodcast.com
© 2020-2025 Ivy Podcast Discovery LLC
